Literature DB >> 35707564

On correlation rank screening for ultra-high dimensional competing risks data.

Xiaolin Chen1, Chenguang Li1, Tao Zhang2, Zhenlong Gao1.   

Abstract

In recent years, numerous feature screening schemes have been developed for ultra-high dimensional standard survival data with only one failure event. Nevertheless, existing literature pays little attention to related investigations for competing risks data, in which subjects suffer from multiple mutually exclusive failures. In this article, we develop a new marginal feature screening for ultra-high dimensional time-to-event data to allow for competing risks. The proposed procedure is model-free, and robust against heavy-tailed distributions and potential outliers for time to the type of failure of interest. Apart from this, it is invariant to any monotone transformation of event time of interest. Under rather mild assumptions, it is shown that the newly suggested approach possesses the ranking consistency and sure independence screening properties. Some numerical studies are conducted to evaluate the finite-sample performance of our method and make a comparison with its competitor, while an application to a real data set is provided to serve as an illustration.
© 2021 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Consistency in ranking; feature screening; model-free; sure independence screening; ultra-high dimensional competing risks data

Year:  2021        PMID: 35707564      PMCID: PMC9042004          DOI: 10.1080/02664763.2021.1884209

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  13 in total

1.  Boosting for high-dimensional time-to-event data with competing risks.

Authors:  Harald Binder; Arthur Allignol; Martin Schumacher; Jan Beyersmann
Journal:  Bioinformatics       Date:  2009-02-25       Impact factor: 6.937

2.  Discussion of "Sure Independence Screening for Ultra-High Dimensional Feature Space.

Authors:  Hao Helen Zhang
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2008-11       Impact factor: 4.488

3.  Penalized variable selection in competing risks regression.

Authors:  Zhixuan Fu; Chirag R Parikh; Bingqing Zhou
Journal:  Lifetime Data Anal       Date:  2016-03-26       Impact factor: 1.588

4.  Penalized estimation for competing risks regression with applications to high-dimensional covariates.

Authors:  Federico Ambrogi; Thomas H Scheike
Journal:  Biostatistics       Date:  2016-04-26       Impact factor: 5.899

5.  Joint Inference for Competing Risks Survival Data.

Authors:  Gang Li; Qing Yang
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

6.  Variable selection in subdistribution hazard frailty models with competing risks data.

Authors:  Il Do Ha; Minjung Lee; Seungyoung Oh; Jong-Hyeon Jeong; Richard Sylvester; Youngjo Lee
Journal:  Stat Med       Date:  2014-07-10       Impact factor: 2.373

7.  The Sparse MLE for Ultra-High-Dimensional Feature Screening.

Authors:  Chen Xu; Jiahua Chen
Journal:  J Am Stat Assoc       Date:  2014       Impact factor: 5.033

8.  Model-Free Feature Screening for Ultrahigh Dimensional Data.

Authors:  Liping Zhu; Lexin Li; Runze Li; Lixing Zhu
Journal:  J Am Stat Assoc       Date:  2012-01-24       Impact factor: 5.033

9.  Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.

Authors:  Lars Dyrskjøt; Karsten Zieger; Francisco X Real; Núria Malats; Alfredo Carrato; Carolyn Hurst; Sanjeev Kotwal; Margaret Knowles; Per-Uno Malmström; Manuel de la Torre; Kenneth Wester; Yves Allory; Dimitri Vordos; Aurélie Caillault; François Radvanyi; Anne-Mette K Hein; Jens L Jensen; Klaus M E Jensen; Niels Marcussen; Torben F Orntoft
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

10.  A selective overview of feature screening for ultrahigh-dimensional data.

Authors:  Liu JingYuan; Zhong Wei; L I RunZe
Journal:  Sci China Math       Date:  2015-08-22       Impact factor: 1.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.